NHS decision to fund new asthma drug a 'beacon of hope' to thousands Around 100,000 people suffering from the worst form of asthma will be given access to a £12,000 treatment that promises the chance of a more normal life.
Health chiefs have said the NHS will pay for injections of Benralizumab for those who cannot be helped by traditional inhalers or steroids.
Patients groups welcomed the decision saying it offers a “beacon of hope” to people suffering from severe eosinophilic asthma, around 1.3 per cent of the 5.4 million living with all forms of the disease. The Daily Telegraph
No comments:
Post a Comment